SOTERA HEALTH COMPANY Foreign Currency Transaction Gain (Loss), Unrealized
SOTERA HEALTH COMPANY (SHC) reported Foreign Currency Transaction Gain (Loss), Unrealized of $4.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-06
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was $2.23M.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was $2.10M.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was -$1.14M, a 109.05% decline year-over-year.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was $10.51M.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for fiscal 2025 was -$9.52M, a 151.90% decline from fiscal 2024.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for fiscal 2024 was $18.34M.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for fiscal 2023 was -$6.06M, a 252.03% decline from fiscal 2022.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), unrealized for fiscal 2022 was $3.98M.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.33M 10-Q · filed 2026-08-06 | $3.19M derived: sum of 3 quarters · filed 2026-08-06 | $13.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.10M 10-Q · filed 2026-05-05 | $963.00K derived: sum of 2 quarters · filed 2026-05-05 | $11.47M derived: sum of 3 quarters · filed 2026-05-05 | -$2.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $9.37M derived: sum of 2 quarters · filed 2026-02-24 | -$4.16M derived: sum of 3 quarters · filed 2026-08-06 | -$9.52M 10-K · filed 2026-02-24 |
| 2025-09-30 | $10.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$3.02M derived: sum of 2 quarters · filed 2026-08-06 | -$8.38M 10-Q · filed 2025-11-04 | $4.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$13.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$18.89M 10-Q · filed 2026-08-06 | -$6.30M derived: sum of 3 quarters · filed 2026-08-06 | -$7.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$5.36M 10-Q · filed 2026-05-05 | $7.22M derived: sum of 2 quarters · filed 2026-05-05 | $6.00M derived: sum of 3 quarters · filed 2026-05-05 | $7.92M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $11.36M derived: sum of 2 quarters · filed 2026-02-24 | $13.28M derived: sum of 3 quarters · filed 2026-02-24 | $18.34M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $694.00K derived: sum of 2 quarters · filed 2025-11-04 | $5.75M 10-Q · filed 2025-11-04 | $2.14M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $6.98M 10-Q · filed 2025-08-08 | $3.37M derived: sum of 3 quarters · filed 2026-02-24 | $5.52M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $5.06M 10-Q · filed 2025-05-01 | $1.45M derived: sum of 2 quarters · filed 2026-02-24 | $3.60M derived: sum of 3 quarters · filed 2026-02-24 | -$194.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.46M derived: sum of 2 quarters · filed 2026-02-24 | -$5.25M derived: sum of 3 quarters · filed 2026-02-24 | -$6.06M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$1.64M derived: sum of 2 quarters · filed 2024-11-05 | -$2.44M 10-Q · filed 2024-11-05 | -$4.07M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$4.60M 10-Q · filed 2024-08-05 | -$6.23M derived: sum of 3 quarters · filed 2025-02-27 | $657.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$802.00K 10-Q · filed 2024-05-02 | -$2.43M derived: sum of 2 quarters · filed 2025-02-27 | $4.46M derived: sum of 3 quarters · filed 2025-02-27 | $5.61M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.26M derived: sum of 2 quarters · filed 2025-02-27 | $6.41M derived: sum of 3 quarters · filed 2025-02-27 | $3.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | $6.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $8.04M derived: sum of 2 quarters · filed 2023-11-01 | $5.61M 10-Q · filed 2023-11-01 | $5.54M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.27M 10-Q · filed 2023-08-03 | -$1.35M derived: sum of 3 quarters · filed 2024-02-27 | -$965.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$2.43M 10-Q · filed 2023-05-03 | -$2.50M derived: sum of 2 quarters · filed 2024-02-27 | -$2.12M derived: sum of 3 quarters · filed 2024-02-27 | -$864.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $309.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.57M derived: sum of 3 quarters · filed 2024-02-27 | -$788.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $382.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.64M derived: sum of 2 quarters · filed 2022-11-02 | -$715.00K 10-Q · filed 2022-11-02 | -$125.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.10M 10-Q · filed 2022-08-04 | -$507.00K derived: sum of 3 quarters · filed 2023-02-28 | $4.63M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$2.35M 10-Q · filed 2022-05-05 | -$1.76M derived: sum of 2 quarters · filed 2023-02-28 | $3.38M derived: sum of 3 quarters · filed 2023-02-28 | $3.37M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $590.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.73M derived: sum of 2 quarters · filed 2023-02-28 | $5.72M derived: sum of 3 quarters · filed 2023-02-28 | $10.60M 10-K · filed 2023-02-28 |
| 2020-09-30 | $5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $5.13M derived: sum of 2 quarters · filed 2021-11-10 | $10.01M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $4.86M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $4.88M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$3.33M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |